Диссертация (1154691), страница 24
Текст из файла (страница 24)
Interleukin-1 beta and neurotrophin-3 synergistically promote neuritegrowth in vitro. // Journal of Neuroinflammation. – 2011. – Vol. 8. – № 1. – P. 183.94. Boeckstyns M., Sorensen A., Vineta J., Rosen B., Navarro X., Archibald S.,Valss-Sole J., Moldovan M., Krarup C. Collagen conduit versus microsurgicalneurorrhaphy:2-yearfollow-upofaprospective,blindedclinicalandelectrophysiological multicenter randomized, controlled trial.
// The Journal of handsurgery. –2013. – Vol. 38. – № 12. – P. 2405–2411.95. Boivin A., Pineau I., Barrette B., Filali M., Vallières N., Rivest S., Lacroix S.Toll-like receptor signaling is critical for Wallerian degeneration and functionalrecovery after peripheral nerve injury. // The Journal of Neuroscience. – 2007. – Vol.27. – № 46. – P. 12565–12576.96.
Boyd J., Gordon T. Neurotrophic factors and their receptors in axonalregeneration and functional recovery after peripheral nerve injury. // Molecularneurobiology. – 2003. – Vol. 27. – № 3. – P. 277–324.13213397. Boylan K., Glass J., Crook J., Yang C., Thomas C., Desaro P., Johnston A.,Overstreet K., Kelly C., Polak M., Shaw G. Phosphorylated neurofilament heavysubunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker inamyotrophic lateral sclerosis.
// Journal of Neurology, Neurosurgery & Psychiatry.– 2013. – Vol. 84. – №4. – P. 467–472.98. Bradke F., Fawcett J. W., Spira M. E. Assembly of a new growth cone afteraxotomy: the precursor to axon regeneration. // Nature reviews Neuroscience. – 2012. –Vol. 13. – №.
3. – P. 183–193.99. Brosius Lutz A. Barres B. Contrasting the glial response to axon injury in thecentral and peripheral nervous systems. // Developmental Cell. – 2014. – Vol. 28.– № 1. – P. 7–17.100.Brunn G., Bungum M., Johnson G., Platt J. Conditional signaling by Toll-like receptor 4. // FASEB journal. – 2005.
– Vol. 19. – № 7. – P. 872–874.101.Campana W. Schwann cells: activated peripheral glia and their role inneuropathic pain. // Brain, behavior, and immunity. – 2007. – Vol. 21. – № 5. – P. 522–527.102.Carmeliet P. Blood vessels and nerves: common signals, pathways anddiseases. // Nature reviews. Genetics. – 2003. – Vol.
4. – № 9. – P. 710–720.103.Caroleo M., Costa N., Bracci-Laudiero L., Aloe L. Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. //Journal of neuroimmunology. – 2001. – Vol. 113. – № 2. – P. 193–201.104.Castellone M., Laatikainen L., Laurila J., Langella A., Hematti P., SoricelliA., Salvatore M., Laukkanen M. Brief report: Mesenchymal stromal cell atrophy incoculture increases aggressiveness of transformed cells. // Stem Cells. – 2013. – Vol.31.
– № 6. – P. 1218–1223.105.Chadwick W., Magnus T., Martin B., Keselman A., Mattson M., MaudsleyS. Targeting TNF-alpha receptors for neurotherapeutics. // Trends in neurosciences, –2008. – Vol. 31. – № 10. – P. 504–511.133134106.Chen Z., Yu W., Strickland S. Peripheral regeneration. // Annual Review ofNeuroscience. – 2007. – Vol.
30. – № 1. – P. 209–233.107.Chen Y.S. Effects of electrical stimulation on peripheral nerveregeneration. // BioMedicine. – 2011. – Vol. 1. – №1. – P. 33-36.108.Chierzi S., Ratto G., Verma P., Fawcett J. The ability of axons toregenerate their growth cones depends on axonal type and age, and is regulated bycalcium, cAMP and ERK. // The European Journal of Neuroscience. – 2005. – Vol. 21.– № 8.
– P. 2051–2062.109.Coleman M., Perry V. Axon pathology in neurological disease: a neglectedtherapeutic target. // Trends in neurosciences. – 2002. – Vol. 25. – № 10. – P. 532–537.110.Coleman M., Freeman M. Wallerian degeneration, wld(s), and nmnat. //Annual review of neuroscience. – 2010. – Vol. 33.
– № 1. – P. 245–267.111.Colognato H., ffrench-Constant C., Feltri M. Human diseases reveal novelroles for neural laminins. // Trends in neurosciences. – 2005. – Vol. 28. – № 9.– P. 480–486.112.Conforti L., Fang G., Beirowski B., Wang M., Sorci L., Asress S., AdalbertR., Silva A., Bridge K., Huang X., Magni G., Glass J., Coleman M. NAD+ and axondegeneration revisited: Nmnat1 cannot substitute for WldS to delay Walleriandegeneration.
// Cell Death and Differentiation. – 2006. – Vol. 14. – № 1. – P. 116–127.113.Daly W., Yao L., Zeugolis D., Windebank A., Pandit A. A biomaterialsapproach to peripheral nerve regeneration: bridging the peripheral nerve gap andenhancing functional recovery. // Journal of the Royal Society, Interface.
– 2012.– Vol. 9. – № 67. – P. 202–221.114.David S, Kroner A. Repertoire of microglial and macrophage responsesafter spinal cord injury. // Nature Reviews Neuroscience. –2011. – Vol. 12. – № 7.– P. 388–399.115.Davy A., Soriano P. Ephrins in vivo: look both ways. // Developmentaldynamics. – 2005. – Vol. 232. – № 1. – P. 1–10.134135116.Dedkov E., Kostrominova T., Borisov A., Carlson B.
Survival of Schwanncells in chronically denervated skeletal muscles. // Acta Neuropathologica. – 2002. –Vol. 103. – № 6. – P. 565–574.117.De S., Trigueros M., Kalyvas A., David S. Phospholipase A2 plays animportant role in myelin breakdown and phagocytosis during Wallerian degeneration. //Molecular and cellular neurosciences. – 2003. – Vol. 24. – № 3.
– P. 753–765.118.DeFrancesco-Lisowitz A., Lindborg J., Niemi J., Zigmond R. Theneuroimmunology of degeneration and regeneration in the peripheral nervous system. //Neuroscience. – 2015. – Vol. 302. – P. 174–203.119.Deumens R., Bozkurt A., Meek M., Marcus M., Joosten E., Weis J., BrookG. Repairing injured peripheral nerves: bridging the gap. // Progress in Neurobiology. –2010. – Vol. 92. – №3. – P. 245–276.120.Dong S., Cheng Y., Yang J., Li J., Liu X., Wang X., Wang D., Krall T.,Delphin E., Zhang C. MicroRNA expression signature and the role of microRNA-21 inthe early phase of acute myocardial infarction. // Journal of Biological Chemistry.
–2009. – Vol. 284. – № 43. – P. 29514-29525.121.English A.W., Schwartz G., Meador W., Sabatier M.J., Mulligan A.Electrical stimulation promotes peripheral axon regeneration by enhanced neuronalneurotrophin signaling. // Developmental Neurobiology. – 2007. – Vol. 67. – № 2. – P.158–172.122.English A.W., Wilhelm J.C., Ward P.J. Exercise, neurotrophins, and axonregeneration in the PNS. // Physiology. – 2014. – Vol. 29. – № 6. – P. 437–445.123.Eichmann A, Makinen T, Alitalo K. Neural guidance molecules regulatevascular remodeling and vessel navigation. // Genes & development. – 2006.
– Vol. 19.– № 9. – P. 1013–1021.124.Erez H., Spira M.E. Local self-assembly mechanisms underlie thedifferential transformation of the proximal and distal cut axonal ends into functional andaberrant growth cones. // The Journal of Comparative Neurology. – 2008. – Vol. 507. –№ 2. – P. 1019–1030.135136125.Faroni A., Mobasseri S., Kingham P., Reid A. Peripheral nerveregeneration: experimental strategies and future perspectives. // Advanced DrugDelivery Reviews.
– 2015. – Vol. 82–83. – P. 160–167.126.Feltri M., Porta D., Previtali S.,Nodari A., Migliavacca B., Cassetti A.,Littlewood-Evans A., Reichardt L., Messing A., Quattrini A., Mueller U., Wrabetz L.Conditional disruption of beta 1 integrin in Schwann cells impedes interactions withaxons. // Journal of the Peripheral Nervous System. – 2002. – Vol. 7. – № 3. – P. 205.127.Filbin M. T. Myelin-associated inhibitors of axonal regeneration in theadult mammalian CNS. // Nature Reviews Neuroscience. – 2003. – Vol.
4. – № 9. – P.703–713.128.Fine E.G., Decosterd I., Papalo¨ızos M., Zurn A., Aebischer P. GDNF andNGF released by synthetic guidance channels support sciatic nerve regeneration acrossa long gap. // The European Journal of Neuroscience. – 2002. – Vol. 15. – № 4. – P.589–601.129.Föhn M., Bannasch H. Artificial skin. // Methods in molecular medicine.
–2007. – Vol. 140. – P. 167–182.130.Frankola K., Greig N., Luo W., Tweedie D. Targeting TNF-α to elucidateand ameliorate neuroinflammation in neurodegenerative diseases. CNS & neurologicaldisorders drug targets. – 2011. – Vol. 10. – № 3. – P. 391–403.131.Gao F., Liu Y., He Y., Yang C., Wang Y., Shi X., Wei G. Hyaluronanoligosaccharides promote excisional wound healing through enhanced angiogenesis. //Matrix Biology. – 2010.
– Vol. 29. – № 2. – P. 107–116.132.Gao Y., Weng C., Wang X. Changes in nerve microcirculation followingperipheral nerve compression. // Neural regeneration research. – 2013. – Vol. 8. – № 11.– P. 1041–1047.133.Gardiner N., Fernyhough P., Tomlinson D., Mayer U., von der Mark H.,Streuli C. Alpha7 integrin mediates neurite outgrowth of distinct populations of adult136137sensory neurons. // Molecular and cellular neurosciences.
– 2005. – Vol. 28. – № 2. – P.229–240.134.Gaudet A., Steeves J., Tetzlaff W., Ramer M. Expression and functions ofgalectin-1 in sensory and motoneurons. // Current drug targets. – 2005. – Vol. 6. – № 4.– P. 419–425.135.Gaudet A., Popovich P., Ramer M. Wallerian degeneration: gainingperspective on inflammatory events after peripheral nerve injury.
// Journal ofneuroinflammation. – 2011. – Vol. 8. – № 1. – P. 110.136.Gaudin R., Knipfer C., Henningsen A., Smeets R., Heiland M., Hadlock T.Approaches to Peripheral Nerve Repair: Generations of biomaterial conduits yielding toreplacing autologous nerve grafts in craniomaxillofacial surgery.
// BioMed researchinternational. – 2016. – Vol. 2016. – P. 3856262.137.George, A., Buehl A., Sommer C. Wallerian degeneration after crush injuryof rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. //Neuroscience Letters.
– 2004. – Vol. 372. – № 3. – P. 215–219.138.George A., Kleinschnitz C., Zelenka M., Brinkhoff J., Stoll G., Sommer C.Wallerian degeneration after crush or chronic constriction injury of rodent sciatic nerveis associated with a depletion of endoneurial interleukin-10 protein. // ExperimentalNeurology. – 2004. – Vol. 188. – № 1. – P. 187–191.139.Ghayemi N., Haghighat A., Amini K., Mohammadi R. Functional effect oflocal administration of glial derived neurotrophic factor combined with inside-out arterygraft on sciatic nerve regeneration in rat.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
